Point72 Asset Management L.P. 13D and 13G filings for X4 Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:18 pm Sale |
2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management L.P. | 913,242 1.300% |
-719,962 (-44.08%) |
Filing |
| 2022-02-14 4:38 pm Purchase |
2021-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management L.P. | 1,633,204 5.800% |
132,961 (+8.86%) |
Filing |
| 2021-11-17 5:27 pm Purchase |
2021-11-09 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Point72 Asset Management L.P. | 1,500,243 5.600% |
1,500,243 (New Position) |
Filing |